Compounds > tobramycin

Page last updated: 2024-08-23

tobramycin and cilastatin, imipenem drug combination

tobramycin has been researched along with cilastatin, imipenem drug combination in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	6 (60.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ariano, RE; Kassum, DA; Meatherall, RC; Patrick, WD	1
Fichtenbaum, CJ; Smith, MJ	1
Hrdy, DB; Kailath, EJ; King, JH	1
Heikkinen, E; Seppänen, J; Uhari, M	1
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M	1
Busuttil, RW; Christou, NV; Dellinger, EP; Solomkin, JS	1
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT	1
Minami, S; Ogake, N; Takahata, M; Yamashiro, Y	1
Cox, JC; Drachman, DA; Hibbard, ML; Kopelman, TR; Maly, TJ; Matthews, MR; O'Neill, PJ; Quan, AN; Vail, SJ	1
Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C	1

Trials

3 trial(s) available for tobramycin and cilastatin, imipenem drug combination

Article	Year
Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections. The Pediatric infectious disease journal, 1992, Volume: 11, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Metronidazole; Tobramycin	1992
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer. Japanese journal of clinical oncology, 1991, Volume: 21, Issue:6 Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome	1991
Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Annals of surgery, 1990, Volume: 212, Issue:5 Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Tobramycin	1990

Other Studies

7 other study(ies) available for tobramycin and cilastatin, imipenem drug combination

Article	Year
Lack of in vitro inactivation of tobramycin by imipenem/cilastatin. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:9 Topics: Anti-Bacterial Agents; Carbenicillin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Interactions; Humans; Imipenem; In Vitro Techniques; Tobramycin	1992
Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Pseudomonas Infections; Tobramycin	1992
Successful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:5 Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Pseudomonas Infections; Risk Factors; Tobramycin	1992
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin	1987
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin	2000
Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia. Surgical infections, 2010, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tobramycin	2010
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support. Anaesthesia, critical care & pain medicine, 2019, Volume: 38, Issue:5 Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin	2019